VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
Amgen Inc. vs EssilorLuxottica
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
EssilorLuxottica
EL · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into EssilorLuxottica's moat claims, evidence, and risks.
View EL analysisComparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 69 / 100 for EssilorLuxottica).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); EssilorLuxottica has 2 segments (52.7% in Direct to Consumer).
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; EssilorLuxottica has 5 across 3.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
EssilorLuxottica
Direct to Consumer
Optical retail and e-commerce (prescription eyewear and sunglasses)
Global
Consumers (end-users)
Omnichannel retailer + vertically integrated manufacturer/brand owner
52.7%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
EssilorLuxottica strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
EssilorLuxottica segments
Full profile >Professional Solutions
Oligopoly
Direct to Consumer
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.